Clinical Trials Directory

Trials / Completed

CompletedNCT00271544

Attain Model 4196 Left Ventricular (LV) Lead

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
190 (actual)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heart beat sometimes an implantable heart device is used to control the rate and rhythm of the heart beat. In certain heart failure cases, when the two lower chambers of the heart no longer beat in a coordinated manner, cardiac resynchronization therapy (CRT) may be prescribed. CRT is similar to a pacemaker. It is placed (implanted) under the skin of the upper chest. CRT is delivered as tiny electrical pulses to the right and left ventricles through three or four leads (flexible insulated wires) that are inserted through the veins to the heart. The purpose of this study is to evaluate a new lead for delivering energy to the left ventricle (bottom left chamber of the heart).

Conditions

Interventions

TypeNameDescription
DEVICEPacing Leadimplant and follow-up of study device

Timeline

Start date
2007-02-01
Primary completion
2007-08-01
Completion
2008-12-01
First posted
2006-01-02
Last updated
2009-09-28
Results posted
2009-08-25

Locations

24 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT00271544. Inclusion in this directory is not an endorsement.